levodopa has been researched along with Mood Disorders in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (19.23) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 8 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagell, P; Iwarsson, S; Nilsson, MH; Odin, P; Rosqvist, K; Storch, A | 1 |
| Campos, FL; Carvalho, MM; Coimbra, B; Lima, R; Pêgo, JM; Rodrigues, AJ; Rodrigues, C; Salgado, AJ; Sousa, N | 1 |
| Fujishiro, H; Kasanuki, K; Nakamura, S | 1 |
| Cohen, AD; Liu, W; Ye, M; Zhang, N; Zhang, Y | 1 |
| Ahn, MH; Chung, SJ; Hong, JP; Kim, J; Kim, MS; Lee, HB; Lee, T | 1 |
| Fox, SH; Lang, AE | 1 |
| Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY | 1 |
| Artemova, IIu; Boĭko, AN; Ganzhula, PA; Ismailov, AM; Ivanov, AK; Khozova, AA; Levin, OS; Lisenker, LN; Nesterova, OS; Otcheskaia, OV; Rotor, LD; Vdovichenko, TV; Zhuravleva, EIu | 1 |
| Delbari, A; Lokk, J; Salman-Roghani, R | 1 |
| Evans, AH; Farrell, MJ; Gibson, SJ; Helme, RD; Lim, SY | 1 |
| Sulkava, R | 1 |
| Agid, Y; Bejjani, BP; Houeto, JL; Mallet, L; Mesnage, V; Welter, ML | 1 |
| Agid, Y; Czernecki, V; Dubois, B; Houeto, JL; Mesnage, V; Pillon, B; Welter, ML | 1 |
| Le Rhun, E; Lebert, F | 1 |
| Cannas, A; Floris, G; Solla, P; Tacconi, P | 1 |
| Durso, R; McNamara, P | 1 |
| de Noordhout, AM; Santens, P | 1 |
| Cardoso, FE; Kummer, A; Maia, DP; Salgado, JV; Teixeira, AL | 1 |
| Dunner, DL | 1 |
| Baum, R; Glantz, R; Klawans, HL; Nausieda, PA; Weber, S | 1 |
| Prange, AJ | 1 |
| Fetoni, V; Girotti, F; Monza, D; Soliveri, P; Testa, D | 1 |
| Belichenko, PV; Orlova, EI; Tsaĭner, B | 1 |
| Brown, RG; Gotham, AM; Marsden, CD; Nissenbaum, H; Quinn, NP; Toone, B | 1 |
| Kamenetskiĭ, VK; Nuller, IuL | 1 |
| Fonda, D | 1 |
6 review(s) available for levodopa and Mood Disorders
| Article | Year |
|---|---|
Levodopa-related motor complications--phenomenology.
Topics: Antiparkinson Agents; Cognition Disorders; Disease Progression; Drug Administration Schedule; Dyskinesias; Fatigue; Humans; Levodopa; Mood Disorders; Motor Activity; Parkinson Disease; Treatment Failure | 2008 |
Differential diagnosis between early Parkinson's disease and dementia with Lewy bodies.
Topics: Brain; Cognition Disorders; Diagnosis, Differential; Disease Progression; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mood Disorders; Parkinson Disease | 2003 |
[Treatment of dementia with Lewy bodies].
Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Case Management; Cholinesterase Inhibitors; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mental Disorders; Mood Disorders; Nootropic Agents; Physical Therapy Modalities; Sleep Wake Disorders; Speech Therapy | 2006 |
Neuropharmacological treatment of mental dysfunction in Parkinson's disease.
Topics: Basal Ganglia; Cholinergic Agents; Cognition Disorders; Dopamine Agonists; Frontal Lobe; Humans; Levodopa; Mood Disorders; Norepinephrine; Parkinson Disease | 2006 |
Novel uses of thyroid hormones in patients with affective disorders.
Topics: Antidepressive Agents; Bipolar Disorder; Electroconvulsive Therapy; Female; Humans; Levodopa; Lithium; Male; Mood Disorders; Parkinson Disease; Thyroid Diseases; Thyroid Gland; Thyroid Hormones | 1996 |
Parkinson's disease in the elderly: psychiatric manifestations.
Topics: Aged; Amantadine; Depression; Humans; Levodopa; Mood Disorders; Parasympatholytics; Parkinson Disease; Personality Disorders | 1985 |
4 trial(s) available for levodopa and Mood Disorders
| Article | Year |
|---|---|
The heterogeneity of non-motor symptoms of Parkinson's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Asian People; Digestive System Abnormalities; Female; Humans; Levodopa; Male; Mental Status Schedule; Metabolic Diseases; Middle Aged; Mood Disorders; Parkinson Disease; Retrospective Studies; Sensation Disorders; Severity of Illness Index; Sleep Wake Disorders; Young Adult | 2015 |
[Effect of dopamine agonist pramipexole (mirapex) on tremor, affective disorders and quality of life in patients with Parkinson's disease].
Topics: Adult; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Pramipexole; Quality of Life; Tremor | 2010 |
Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Central Nervous System Stimulants; Cognition Disorders; Double-Blind Method; Female; Humans; Levodopa; Male; Methylphenidate; Middle Aged; Mood Disorders; Neuropsychological Tests; Physical Therapy Modalities; Psychiatric Status Rating Scales; Retrospective Studies; Stroke; Time Factors; Treatment Outcome | 2011 |
Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy.
Topics: Antiparkinson Agents; Depression; Humans; Levodopa; Middle Aged; Mood Disorders; Multiple System Atrophy; Parkinson Disease | 1999 |
16 other study(ies) available for levodopa and Mood Disorders
| Article | Year |
|---|---|
Dopaminergic Effect on Non-Motor Symptoms in Late Stage Parkinson's Disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cognition Disorders; Dopamine Agents; Fatigue; Female; Humans; Levodopa; Male; Mood Disorders; Parkinson Disease; Treatment Outcome | 2018 |
Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits.
Topics: Adrenergic Agents; Animals; Antidepressive Agents; Antiparkinson Agents; Behavior, Animal; Bupropion; Disease Models, Animal; Immunohistochemistry; Levodopa; Mood Disorders; Motor Activity; Oxidopamine; Parkinsonian Disorders; Paroxetine; Rats; Rats, Wistar | 2013 |
Levodopa treatment and mood fluctuation in dementia with Lewy bodies: a case report.
Topics: Affect; Aged; Comorbidity; Dopamine Agents; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levodopa; Lewy Body Disease; Mood Disorders; Treatment Outcome | 2013 |
Increased suicide risk and clinical correlates of suicide among patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Case-Control Studies; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Suicide | 2016 |
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome | 2009 |
Dyskinetic patients show rebound worsening of affect after an acute L-dopa challenge.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Mood Disorders; Parkinson Disease; Regression Analysis; Severity of Illness Index; Time Factors | 2012 |
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
Topics: Confusion; Depression; Dopamine Agonists; Electric Stimulation Therapy; Follow-Up Studies; Levodopa; Mood Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease; Quality of Life; Social Behavior Disorders; Substance Withdrawal Syndrome; Subthalamic Nucleus; Time; Treatment Outcome | 2003 |
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?
Topics: Antiparkinson Agents; Deep Brain Stimulation; Extinction, Psychological; Female; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Motivation; Neurosurgical Procedures; Parkinson Disease; Reward; Severity of Illness Index; Subthalamic Nucleus | 2005 |
Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation.
Topics: Antiparkinson Agents; Benserazide; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Homeostasis; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Paraphilic Disorders; Parkinson Disease; Pedophilia; Pergolide | 2006 |
Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire: a Belgian multicenter survey.
Topics: Aged; Antiparkinson Agents; Anxiety; Belgium; Humans; Levodopa; Mood Disorders; Movement Disorders; Parkinson Disease; Surveys and Questionnaires | 2006 |
Dopamine dysregulation syndrome in Parkinson's disease: case report.
Topics: Aged; Antiparkinson Agents; Dopamine; Humans; Levodopa; Male; Mood Disorders; Parkinson Disease; Substance-Related Disorders; Syndrome | 2006 |
Sub-types of bipolar affective disorder with particular regard to bipolar II.
Topics: Adult; Bipolar Disorder; Catechol O-Methyltransferase; Diagnosis, Differential; Humans; Levodopa; Lithium; Lithium Carbonate; Mood Disorders; Suicide, Attempted | 1983 |
Psychiatric complications of levodopa therapy of Parkinson's disease.
Topics: Circadian Rhythm; Hallucinations; Humans; Hydrocortisone; Levodopa; Mental Disorders; Mood Disorders; Parkinson Disease; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Thinking | 1984 |
[Biochemical aspects of the pathogenesis of autonomic and emotional disorders in functional disorders of the dopamine system].
Topics: Animals; Autonomic Nervous System Diseases; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Disease Models, Animal; Dopamine; Hypothalamus; Levodopa; Male; Mood Disorders; Parasympathetic Nervous System; Rats; Rats, Inbred Strains; Synaptosomes | 1991 |
Mood swings associated with the 'on-off' phenomenon in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Parkinson Disease, Secondary | 1987 |
[Features of affective disorders in patients with vascular parkinsonism].
Topics: Aged; Anxiety; Cerebrovascular Disorders; Depression; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Mood Disorders; Parasympatholytics; Parkinson Disease, Secondary | 1987 |